← SEC 公告列表 | INCY SEC 公告 | 因塞特醫療(INCY)

重大事件 即時報告 8-K 2026-06-22

INCYTE提交8-K報告 披露未具體說明重大事件

於 SEC 網站開啟原文

AI 繁中摘要

Incyte Corporation(股票代碼:INCY)於2026年6月22日向美國證監會提交了一份8-K當前報告(申報類型:8-K,項目8.01其他事件)。該報告僅披露公司發生了一項未具體說明的重大事件,但未有提供該事件的詳細內容或影響分析。投資者需留意後續可能發布的補充公告或更新文件,以了解該事件對公司營運、產品管線及財務狀況的潛在影響。
展開英文正文
EDGAR Filing Documents for 0000879169-26-000046

 
 
 
 
 
 
 

 
 
 SEC.gov
 
 

 
 EDGAR
 

 

 
 
 Latest Filings 
 

 
 Filings search tools
 

 
 
 Filing Detail

 
 SEC Home »

 Company Search »

 Current Page

 

 
 
 Form 8-K - Current report: 
 

 
 SEC Accession No. 0000879169-26-000046
 

 

 
 
 
 Filing Date

 2026-06-22

 Accepted

 2026-06-22 07:00:40

 Documents

 11

 

 
 Period of Report

 2026-06-22

 

 
 Items

 Item 8.01: Other Events

 

 

 
  Interactive Data
 

 

 

 
 Document Format Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 1
 8-K
 incy-20260622.htm   iXBRL
 8-K
 23054
 

 
  
 Complete submission text file
 0000879169-26-000046.txt
  
 136693
 

 
 

 
 Data Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 2
 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
 incy-20260622.xsd
 EX-101.SCH
 1779
 

 
 3
 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
 incy-20260622_lab.xml
 EX-101.LAB
 21629
 

 
 4
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
 incy-20260622_pre.xml
 EX-101.PRE
 12506
 

 
 14
 EXTRACTED XBRL INSTANCE DOCUMENT
 incy-20260622_htm.xml
 XML
 2715
 

 
 

 Mailing Address
 1801 AUGUSTINE CUT-OFF
 
WILMINGTON DE
19803 
 

 Business Address
 1801 AUGUSTINE CUT-OFF
 
WILMINGTON DE
19803 
 3024986700
 

 INCYTE CORP (Filer)
 CIK: 0000879169 (see all company filings)
EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 261104873
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)